• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States.

作者信息

King Jordan B, Sakhuja Swati, Derington Catherine G, Kolm Paul, Herrick Jennifer S, Berchie Ransmond O, Shen Jincheng, Greene Tom, Tajeu Gabriel S, Howard George, Levitan Emily B, Muntner Paul, Safford Monika M, Ying Jian, Weintraub William S, Moran Andrew E, Bress Adam P, Bellows Brandon K

机构信息

Department of Population Health Sciences University of Utah Salt Lake City UT USA.

Institute for Health Research Kaiser Permanente Colorado Aurora CO USA.

出版信息

J Am Heart Assoc. 2024 Sep 17;13(18):e034515. doi: 10.1161/JAHA.124.034515. Epub 2024 Sep 9.

DOI:10.1161/JAHA.124.034515
PMID:39248269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11935606/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1928/11935606/dd6a98e14e27/JAH3-13-e034515-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1928/11935606/dd6a98e14e27/JAH3-13-e034515-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1928/11935606/dd6a98e14e27/JAH3-13-e034515-g001.jpg

相似文献

1
Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States.美国实施强化收缩压目标的年度成本。
J Am Heart Assoc. 2024 Sep 17;13(18):e034515. doi: 10.1161/JAHA.124.034515. Epub 2024 Sep 9.
2
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.35至74岁成年人中保守或强化血压治疗指南的比较成本效益：心血管疾病政策模型
Hypertension. 2016 Jul;68(1):88-96. doi: 10.1161/HYPERTENSIONAHA.115.06814. Epub 2016 May 15.
3
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review.抗高血压药物治疗评估中的血压降低、持续性及成本——综述
Cardiovasc Diabetol. 2009 Mar 27;8:18. doi: 10.1186/1475-2840-8-18.
4
Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review.家庭血压监测在高血压诊断和治疗中的应用：系统评价。
Am J Hypertens. 2011 Feb;24(2):123-34. doi: 10.1038/ajh.2010.194. Epub 2010 Sep 9.
5
Cost-effectiveness of Intensive Blood Pressure Management.强化血压管理的成本效益。
JAMA Cardiol. 2016 Nov 1;1(8):872-879. doi: 10.1001/jamacardio.2016.3517.
6
Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).在美国采用收缩压干预试验（SPRINT）强化血压治疗方案避免的潜在死亡和发生的严重不良事件：来自美国国家健康与营养检查调查（NHANES）的预测
Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13.
7
Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia.模拟改善心血管疾病风险干预措施对俄罗斯临床和经济结果的影响。
PLoS One. 2014 Aug 20;9(8):e103280. doi: 10.1371/journal.pone.0103280. eCollection 2014.
8
The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial.每日短信提醒在老年人药学服务中提高患者抗高血压药物依从性的效果（SPPA）：一项随机对照试验的研究方案
Trials. 2017 Jul 18;18(1):334. doi: 10.1186/s13063-017-2063-8.
9
Higher blood pressure targets for hypertension in older adults.老年人高血压的更高血压目标
Cochrane Database Syst Rev. 2024 Dec 17;12(12):CD011575. doi: 10.1002/14651858.CD011575.pub3.
10
Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.在中国人群中开展收缩压干预试验（SPRINT）的适用性和成本效益：一项成本效益建模研究。
PLoS Med. 2021 Mar 4;18(3):e1003515. doi: 10.1371/journal.pmed.1003515. eCollection 2021 Mar.

本文引用的文献

1
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults.SPRINT 资格美国成年人强化收缩压治疗的预估人群健康获益。
Am J Hypertens. 2023 Aug 5;36(9):498-508. doi: 10.1093/ajh/hpad047.
2
Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 to 2016.美国心血管疾病和心血管风险因素的支出：1996 年至 2016 年。
Circulation. 2021 Jul 27;144(4):271-282. doi: 10.1161/CIRCULATIONAHA.120.053216. Epub 2021 Apr 30.
3
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.
强化血压控制与标准血压控制的成本效益
N Engl J Med. 2017 Aug 24;377(8):745-755. doi: 10.1056/NEJMsa1616035.
4
Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).在美国采用收缩压干预试验（SPRINT）强化血压治疗方案避免的潜在死亡和发生的严重不良事件：来自美国国家健康与营养检查调查（NHANES）的预测
Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13.
5
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.